Get started
UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303

UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsSeasonalsBonds

Trade ideas

UNH set to breach 430$ in the near termNYSE:UNH UnitedHealth Group Incorporated (UNH) is showing all the technical and fundamental signs of a major bullish reversal. After a steep decline, the weekly chart has now triggered a powerful signal: the 9-period Simple Moving Average (SMA) has crossed above the 20-period SMA, confirming short-term momentum and marking the start of a new uptrend. This crossover, highlighted in the chart, historically precedes large moves higher, especially when supported by rising trading volume and positive company developments. What’s even better, UNH just released robust earnings that beat market expectations, demonstrating the company's resilience and growth potential even in challenging environments. Q3 revenue reached $113.2 billion, a 12% year-over-year increase driven by double-digit growth in both UnitedHealthcare and Optum segment Technically, there’s a clear path towards the near-term resistance around $436, and a break above this level could open the door for a run back to previous highs near $487. With a recovery in fundamentals and a high-probability technical setup, UNH now has the potential to deliver gains of over 40% from current prices—backed by both chart dynamics and a strong earnings trend.
NYSE:UNHLong
by warenabuff
Breaking: UnitedHealth Group Incorporated (UNH) Up 4% PremarketThe share price of UnitedHealth Group Incorporated (NYSE: NYSE:UNH ) is up 4% in Tuesday's premarket session as the company reports earnings results 28 October, 2025 before the bell. UnitedHealth Group raised its 2025 earnings outlook to reflect net earnings of at least $14.90 per share and adjusted net earnings of at least $16.25 per share. Third Quarter 2025 Key Performance Metrics Consolidated revenues of $113.2 billion, up 12% year-over-year. Earnings from operations were $4.3 billion; net margin of 2.1%. Adjusted EPS of $2.92; GAAP EPS of $2.59. Medical care ratio (MCR) of 89.9% was in line with expectations outlined in the second quarter 2025. Operating cost ratio of 13.5% reflecting investments to support future growth. UnitedHealthcare revenues grew 16% year-over-year to $87.1 billion, driven by growth in Medicare & Retirement and Community & State; UnitedHealthcare served 50.1 million consumers domestically, up 795,000 year-over-year. Optum revenues grew 8% year-over-year to $69.2 billion, driven by growth in Optum Rx. September 30, 2025, debt-to-capital ratio of 44.1% unchanged from the second quarter 2025 and inclusive of the impact of closing the Amedisys transaction on August 14, 2025. Technical Outlook With the RSI at 58, NYSE:UNH is poised to break the $381 resistant zone paving the way for a much more greater strides. Similarly, on a more bullish tone, the stock's moving averages have cross paths indicating possible resurgence of a golden cross.
NYSE:UNHLong
by DEXWireNews
UNH: Bounce or Breakdown? Watch This LevelLooks like the buyers are stepping in — short covering? Dead cat bounce? Or real value buyers? Time will answer that, but here’s what we do know: the stock is trading at the same levels it did when it was earning half as much. All the investigations and allegations? Priced in. But here’s the kicker: why is UNH leading the gainers in the Dow when the Dow itself is red? If it holds here and pops a few points, we might see a real run. ⚠️ Caution: This is a high-volatility name. If you’re still learning, use stops, stay small — or better yet, just paper trade and pay with your time, not your capital. 😉 #unh #unitedhealthcare
NYSE:UNHLong
by onlytrade2win
UNH | Oversold Giant Setting Up for a Rebound?📰 What’s happening? UnitedHealth ( NYSE:UNH ) just made headlines after Berkshire Hathaway disclosed a multi-billion stake, fueling one of the stock’s strongest single-day rallies in years. This comes on the back of months of selling pressure tied to the DOJ probe, CEO changes, and suspended guidance. Now, the question is: Was that the bottom, or just a pause in the storm? 📉 Trade Setup (Swing Idea) 🟢 Entry Zones $304 (current level – speculative buy) $280 (support zone) $250 (deep pullback entry) 🎯 Profit Targets TP1: $325 (short-term resistance) TP2: $340 TP3: $355 📌 Takeaway This is a high-risk, high-reward swing trade. Oversold conditions and Buffett’s backing could drive a rebound toward $325–$355, but legal and regulatory risks remain a heavy cloud. Manage position size and keep stops in place. ⚠️ Disclaimer: This is not financial advice. Trading involves risk. Do your own research and use proper risk management
NYSE:UNHLong
by Robert_V12
2
$UNH has nothing to do with China-US trade war.- NYSE:UNH has nothing to do with China-US trade war because all of its business is in US. - Companies which will get hurt by China - US tensions would be MNCs ( multi national companies) , Chips related companies, Retail like clothing, beauty products and some healthcare which get raw materials from the china for drug. - Insurance related companies should do well amidst this macro development. - NYSE:UNH selling on china related trade war is so stupid and I believe it's algorithmic selling but once institutional investors and fund managers come back to senses. - They should consider parking money in NYSE:UNH for safe compounding amidst this new macro shenanigan. - NYSE:UNH is still undervalued, defensive & doesn't have any exposure to US-china trade wars. - NYSE:UNH is increasing rates for premium starting 2026 that's one more big tailwind.
NYSE:UNHLong
by bigbull037
$UNH Testing All-Time High AVWAPNYSE:UNH is currently testing its All-Time High Anchored Volume Weighted Average Price (ATH AVWAP), while simultaneously forming what appears to be a flat base. In pre-market trading today, the stock price has moved above the AVWAP, potentially indicating reduced overhead resistance and the possibility for continued upward momentum. Position and Strategy I initiated a position in NYSE:UNH on August 13th and have steadily increased my holdings up to and including yesterday. As the stock approaches a critical juncture, there is potential for it to continue rallying, especially with earnings scheduled to be announced in 25 days. Analyst Ratings and Price Targets The consensus among analysts is generally positive for NYSE:UNH , with 16 rating it as a buy or strong buy, 7 assigning a hold rating, and 3 recommending a sell. The highest 12-month price target currently stands at $440. Future Plans If NYSE:UNH can move above the $362 level, I plan to further increase my already oversized position, as this would present a compelling opportunity to at least fill the gap.
NYSE:UNHLong
by Brent_Calver
UNH Stock Technical Outlook – Bullish Momentum Confirmed😎 UNH Wealth Heist: Swing Trade Strategy Map 🤑💰 Asset: UnitedHealth Group Incorporated ( NYSE:UNH ) Market: US Stock Market Strategy: Swing Trade (Thief Style 🕵️‍♂️) 📈 The Setup: Bullish Breakout in Sight! 🚀 Ladies and Gentlemen, welcome to the Thief OG playbook! 📖 NYSE:UNH is setting up for a potential bullish run, and we’re ready to layer our entries like masterminds! 🧠 Here’s the breakdown of this sneaky swing trade setup: 🌟 Bullish Trend Confirmation: The chart is screaming uptrend! We’ve got strong upside pressure from a demand zone 📍, signaling buyers are ready to pounce. ✨ Golden Cross Alert: The Hull Moving Average (HMA) at 786 periods has crossed above the price candles, confirming a bullish momentum shift. 🚀 🐍 Re-accumulation Phase: The stock is consolidating, building energy for the next leg up. It’s like NYSE:UNH is coiling for a big breakout! 💥 🕵️‍♂️ Entry Plan: The Thief Layering Strategy 🎯 We’re not just entering; we’re layering our entries like pros! 😎 The Thief Strategy uses multiple buy limit orders to scale into the trade with precision. Here’s how to set it up: 📊 Entry Levels: Place buy limit orders at $320.00, $330.00, $340.00, $350.00. Pro Tip: Feel free to add more layers based on your risk appetite and account size! More layers = more chances to catch the move. 🔍 Why Layering?: This method spreads your entry across key support levels, reducing risk and maximizing potential. It’s like planting multiple traps for profits! 🪤 🛑 Stop Loss: Protect Your Loot! 🔒 🛡️ Thief Stop Loss: Set a stop loss at $300.00. 📝 Note: Dear Thief OGs, this is my suggested stop loss, but it’s your heist! Adjust based on your risk tolerance. Take the money and run at your own discretion! 😏 🎯 Target: Cashing Out Like a Boss 💸 💰 Profit Target: Aim for $420.00, where the Simple Moving Average (SMA) acts as a strong resistance. ⚠️ Why This Level?: The SMA has historically capped rallies, and we’re seeing signs of overbought conditions with a potential trap for late buyers. Escape with your profits before the trap springs! 🏃‍♂️ 📝 Note: As always, Thief OGs, this is my suggested target. You decide when to pocket the gains — it’s your heist, your rules! 😎 👀 Related Pairs to Watch 🔎 To keep your eyes on the market’s pulse, here are correlated assets to monitor alongside NYSE:UNH : 📈 NYSE:CI (Cigna Corporation): Another healthcare giant, often moves in tandem with NYSE:UNH due to sector trends. Watch for similar bullish setups or divergences. 🩺 📊 NYSE:HUM (Humana Inc.): A key player in the health insurance space, showing high correlation with $UNH. If NYSE:HUM breaks out, it could confirm NYSE:UNH ’s move. 🚀 📡 AMEX:XLV (Health Care Select Sector SPDR Fund): This ETF tracks the broader healthcare sector. A bullish AMEX:XLV strengthens the case for NYSE:UNH ’s rally. 🌟 Key Correlation Point: NYSE:UNH , NYSE:CI , and NYSE:HUM often react to healthcare policy news, earnings cycles, and sector sentiment. Keep an eye on AMEX:XLV for broader sector confirmation. If AMEX:XLV is pumping, NYSE:UNH is likely to follow! 📊💥 📝 Final Notes for the Heist This setup is designed for Thief OG traders who love a calculated, stylish swing trade. The layering strategy gives you flexibility, the bullish signals provide confidence, and the target keeps it profitable. But always remember: trade at your own risk, and don’t get caught in the market’s traps! 😜 ✨ “If you find value in my analysis, a 👍 and 🚀 boost is much appreciated — it helps me share more setups with the community!” Disclaimer: This is a Thief Style trading strategy, crafted for fun and educational purposes. Always do your own research and manage your risk. Trading involves risks, and I’m not responsible for any losses. Stay sharp, Thief OGs! 🕵️‍♂️ #UNH #SwingTrade #LayeredEntry #ThiefStrategy #StockMarket #HealthcareStocks #TradingIdeas #BullTrend #TechnicalAnalysis #GoldenCross #MarketWealthMap #TradingView
NYSE:UNHLong
by The-Thief
2
UNH LONGOh man, what a chart to dig into. (Read the fundamental analysis for this one—I don’t look into company financials or earnings. I’m also not following the news, so that’s on you. I’ve seen too many setups fail because of some unexpected headline or a random tweet on a f***ing Monday from the orange man.) Why am I looking at this setup? We’re sitting right at the 0.618 fib in a bullish trend. That lines up with the POC of a B-shaped volume profile, right at a support level. On top of that, liquidity under the trendline on the left has already been swept, and price is way overstretched from VWAP. So even if this isn’t a full reversal, we should at least get a pullback back toward the VWAP midline. entries at 301 283 264 SL at 236 TP 50% at 492, and let the rest rides There’s a lot going on here: Trend direction is still up. As long as we don’t get a close below 187, this is just a pullback. VWAP is miles away from the current price. Price doesn’t stay that far from it forever—it either pulls back or consolidates before heading higher. Fibs and TLs: There’s a major trendline (marked as Area 2) that hasn’t been touched for the third time yet. That same zone lines up with the 0.78 fib. Price hasn’t reached it yet—might not—but that’s still a spot I’d seriously consider for a long. POC zone: The marked long area is right on the POC of a B-profile. It’s a key level and should act as support. That’s a solid place to look for a bounce. I’ve marked out the setup and three possible entries. These are the spots I’d look to long from. If they all fail, then Area 2 is the backup—it should hold. One more thing: there’s a red line in the middle of the chart. If you want more confirmation, wait for price to close above it, then catch the retrace. That gives you more confidence in the setup. Do your own analysis and keep an eye on the news. TA only works if it lines up with the fundamentals. If not, it’s useless.
NYSE:UNHLong
by lojjkkjvvv
KISS : Keep it simple! $UNH Breakout play! - NYSE:UNH offers best risk to reward fundamentally for 2026. Premium increase is coming in 2026, that will boost the fundamentals and improve margins and boost revenue and free cash flow. - I'm not gonna repeat my fundamental thesis. Please see my older post. - For this post, just highlighting the technical breakout. - NYSE:UNH has been beautifully grinding higher, pulling back, consolidating and then breaking out. This is exactly you want to see as a long term investor for a compounding machine. - Breakout also helps momentum traders to ride the wave.
NYSE:UNHLong
by bigbull037
UnitedHealth Group approaches key support for a potential rally Current Price: $336.69 Direction: LONG Targets: - T1 = $345.50 - T2 = $355.00 Stop Levels: - S1 = $330.00 - S2 = $325.00 **Wisdom of Professional Traders:** This analysis synthesizes insights from thousands of professional traders and market experts, leveraging collective intelligence to identify high-probability trade setups with UnitedHealth Group. Experienced traders highlight the importance of focusing on sector strength, earnings stability, and macroeconomic tailwinds to find potential upside opportunities within the healthcare sector, where UnitedHealth Group remains a flagship performer. **Key Insights:** UnitedHealth Group benefits from its core position as the largest healthcare insurance provider in the U.S., with consistent revenue growth attributed to strong enrollment numbers and diversification through ancillary services like Optum. Seasonal enrollment periods, combined with robust pricing adjustments in 2025, are expected to drive revenue growth in coming quarters. Additionally, its operational efficiency has allowed it to mitigate rising medical costs better than competitors, a vital edge within the current inflationary environment. Global healthcare spending trends in 2025 also favor UnitedHealth as demand for services increases with demographics shifting toward insured care, and new payment models emerge to deliver cost efficiencies. Analysts further note that UnitedHealth’s expansion in tech-enabled health services positions it to improve data utilization while reducing costs, adding high-margin growth opportunities to its portfolio. **Recent Performance:** UnitedHealth Group has traded in a tight range in recent weeks, consolidating around the $330-$340 zone. The stock experienced a pullback after reaching higher levels earlier in the year but is showing signs of stabilization as traders anticipate stronger Q3 results. Healthcare equities have generally lagged broader indices after an initial standout performance earlier in 2025, but UnitedHealth is now approaching technical support levels that suggest potential upside. **Expert Analysis:** Analysts point to UnitedHealth Group’s solid fundamentals, including its high-margin Optum division, favorable regulatory risk management, and expanding customer base. From a technical perspective, the stock’s recent consolidation pattern amid sector weakness offers an optimal risk/reward setup for traders eager to capture rebounds within the defensive healthcare sector. The RSI for UnitedHealth suggests oversold conditions, aligning with price action leaning towards recovery. Moving averages indicate that once resistance at $345 is approached, momentum may shift bullish, presenting an opportunity to test deeper levels at $355 in an upward trend line. **News Impact:** Recent announcements of regulatory reforms aimed at reducing healthcare costs are anticipated to benefit UnitedHealth by accelerating adoption of efficient care models across its service locations. Additionally, news of strategic investments in proprietary technology platforms by UnitedHealth has further emphasized the company’s commitment to enhancing data-driven efficiencies. Positive earnings sentiment heading into Q3 has helped buoy confidence, catalyzing strong investor interest at current levels. **Trading Recommendation:** UnitedHealth Group presents a compelling long position opportunity as it approaches strong support at $336.69, strategically positioned for growth heading into Q3 2025. Traders are advised to target $345.50 with a secondary upside target of $355.00 as macroeconomic tailwinds favor defensive positions within healthcare. A stop level at $330 protects downside risk, with additional protection at $325 to account for short-term volatility. This setup leverages strong fundamentals, technical indicators, and sector momentum, all aligning with a bullish bias for UnitedHealth Group over the next quarter. Do you want to save hours every week? Register for the free weekly update in your language!
NYSE:UNHLong
by CrowdWisdomTrading
UNH - Awaiting Dip OpportunityUNH seems to have lagged a little even with S&P at all time high's, I'm a big fan of this stock long-term, but I always like to be able to buy on a pullback. Would love a retest of this trendline ccoinciding with that key VPR zone from earlier consolidation. Those 2 points meet October 8th, interested to see what happens, if we see a pullback as listed I'm hopping in to make some serious pennies. Wave-Count Confidence: Below Average/Weak Unfamiliar long-term structure, and overall odd's are weak for this playing out. But a man can wish.
NYSE:UNH
by ThePennyMan
UNH – Break of Downtrend, Bullish Setup EmergingUnitedHealth (UNH) has recently broken out of a sustained downtrend, signaling a potential shift in momentum. The stock is now retesting near-term levels, with the green uptrend line providing structural support for further upside. 🔍 Technical Analysis Current Price: $347.89 Trend: Downtrend in red broken, new uptrend support holding. Support & Stop-Loss: $321 | SL: $311 (Medium risk – 4H support) $280 | SL: $273 (Swing entry if reached – daily support) Bias: Bullish while above $321. 🧭 Outlook Bullish Case: Holding $321 paves the way for continued upside, potentially retesting prior breakdown levels. Bearish Case: Losing $321 would weaken momentum, shifting focus toward the $280 swing support zone. 🌍 Fundamental View UNH remains one of the largest healthcare insurers, benefiting from strong cash flows and defensive demand. Risks include higher medical cost ratios and policy uncertainties in U.S. healthcare. Valuation: While not “cheap,” UNH’s strong earnings base and dividend growth support long-term attractiveness compared to peers. ⚠️ Disclaimer This analysis is for educational purposes only and does not constitute financial advice.
NYSE:UNH
by husseindergham
1
UNITEDHEALTH UNH Long Scenario based on Seasonality and FractalsFrom a fractals Perspective I expect a chance for around 30% gain from an upcoming upmove. From a Seasonal Perspective I expect a retracement mode until End of Mid/September and then upside until early December. I hope we make the bigger upmove in this time and complete that move otherwise this fractals target could take some time/moths/years. Feel free to like / support the Idea, leave a comment or contact me in the chat. Good luck to all *this is not a trade call* Cheers!
GETTEX:UNHLong
by Amazing-Fractals